CPH
C Partners Holding Portfolio holdings
AUM
$455M
This Quarter Return
+1.57%
1 Year Return
+22.57%
3 Year Return
+65.69%
5 Year Return
+108.46%
10 Year Return
+270.06%
AUM
$309M
AUM Growth
–
Cap. Flow
+$309M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
65.87%
Holding
49
New
49
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
$108M |
| 2 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$35M |
| 3 |
Royal Gold
RGLD
|
$12.4M |
| 4 |
Wheaton Precious Metals
WPM
|
$12.3M |
| 5 |
Johnson & Johnson
JNJ
|
$7.23M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 18.25% |
| 2 | Materials | 12.77% |
| 3 | Consumer Discretionary | 6% |
| 4 | Technology | 4.04% |
| 5 | Consumer Staples | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MSC Industrial Direct
MSM
$5.02B
| $3.91M | 1.27% |
+48,144
| New | +$3.91M |
|
27
Alphabet (Google) Class C
GOOG
$2.58T
| $3.75M | 1.21% |
+7,089
| New | +$3.75M |
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $3.47M | 1.12% |
+31,000
| New | +$3.47M |
|
29
Viatris
VTRS
$12.3B
| $3.27M | 1.06% |
+58,000
| New | +$3.27M |
|
30
Gilead Sciences
GILD
$140B
| $3.07M | 1% |
+32,600
| New | +$3.07M |
|
31
Abbott
ABT
$231B
| $2.35M | 0.76% |
+52,137
| New | +$2.35M |
|
32
Biogen
BIIB
$19.4B
| $1.73M | 0.56% |
+5,100
| New | +$1.73M |
|
33
AbbVie
ABBV
$372B
| $1.7M | 0.55% |
+26,000
| New | +$1.7M |
|
34
Cardinal Health
CAH
$35.5B
| $1.7M | 0.55% |
+21,000
| New | +$1.7M |
|
|
PCYC
35
DELISTED
PHARMACYCLICS INC
PCYC
| $1.65M | 0.54% |
+13,500
| New | +$1.65M |
|
36
Pfizer
PFE
$141B
| $1.56M | 0.5% |
+50,000
| New | +$1.56M |
|
37
Teva Pharmaceuticals
TEVA
$21.1B
| $1.5M | 0.48% |
+26,000
| New | +$1.5M |
|
38
IQVIA
IQV
$32.4B
| $1.47M | 0.48% |
+25,000
| New | +$1.47M |
|
39
Revvity
RVTY
$10.5B
| $1.44M | 0.47% |
+33,000
| New | +$1.44M |
|
|
HPTX
40
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.42M | 0.46% |
+59,000
| New | +$1.42M |
|
41
Perrigo
PRGO
$3.27B
| $1.03M | 0.33% |
+6,162
| New | +$1.03M |
|
|
ELGX
42
DELISTED
Endologix Inc
ELGX
| $867K | 0.28% |
+56,722
| New | +$867K |
|
43
Thermo Fisher Scientific
TMO
$186B
| $789K | 0.26% |
+6,300
| New | +$789K |
|
44
Stryker
SYK
$150B
| $755K | 0.24% |
+8,000
| New | +$755K |
|
45
Boston Scientific
BSX
$156B
| $729K | 0.24% |
+55,000
| New | +$729K |
|
|
BDSI
46
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $661K | 0.21% |
+55,000
| New | +$661K |
|
|
RVNC
47
DELISTED
Revance Therapeutics, Inc.
RVNC
| $407K | 0.13% |
+24,000
| New | +$407K |
|
48
Dynavax Technologies
DVAX
$1.19B
| $349K | 0.11% |
+20,697
| New | +$349K |
|
|
SCPX
49
DELISTED
Scorpius Holdings, Inc.
SCPX
| $230K | 0.07% |
+50,000
| New | +$230K |
|